Document Detail

Precommitted erythroid cells enriched in cultures of suboptimally induced Friend erythroleukemia cells.
MedLine Citation:
PMID:  3478103     Owner:  NLM     Status:  MEDLINE    
In the presence of suboptimal inducing amounts of dimethylsulfoxide or hexamethylenebisacetamide, a major proportion of uncommitted murine erythroleukemia (MEL) cells was found to be precommitted or primed for commitment, which was demonstrated by their rapid commitment to terminal differentiation when recultured for short periods of time (three to six hours) with fresh inducer. These same cells did not commit if left in the original inducer-containing media or if replated in fresh media without inducer. The two inducers could be interchanged in the priming and postpriming period without affecting the commitment event. However, hemin, an agent that induces hemoglobin synthesis without commitment, showed no ability to enhance commitment of a primed cell population. The rapid commitment of primed cells was inhibited by 12-O-tetradecanoylphorbol-13-acetate and cordycepin but not by cycloheximide. The latter finding indicated that this rapid inducer-dependent commitment event required new RNA synthesis but not new protein synthesis. The precommitment state was lost within six hours of the growth of cells in the absence of inducer but could be sustained longer if cells were incubated in cycloheximide. These studies characterize a precommitment state not previously described and one that appears during chemically induced differentiation in the absence of metabolic inhibitors. The stabilization of these precommitted cells by cycloheximide suggests that the reversibility of precommitment involves new protein synthesis. These findings show that MEL cells proceed to terminal differentiation by accumulating unstable products that must be maintained by the inducer until the final commitment event.
E DiMambro; M Galanti; S B Levy
Related Documents :
357163 - Ontogeny of b lymphocyte function. vi. ontogeny of thymus cell capacity to facilitate t...
15010323 - Derivation, propagation and differentiation of human embryonic stem cells.
10857613 - Electrothermal atomic absorption spectrometric diagnosis of familial hypercholesterolemia.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Blood     Volume:  70     ISSN:  0006-4971     ISO Abbreviation:  Blood     Publication Date:  1987 Nov 
Date Detail:
Created Date:  1987-12-11     Completed Date:  1987-12-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1565-71     Citation Subset:  AIM; IM    
Department of Medicine, Tufts University School of Medicine, Boston, MA 02111.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetamides / pharmacology
Cell Differentiation / drug effects
Cell Line
Dimethyl Sulfoxide / pharmacology
Heme / pharmacology
Leukemia, Erythroblastic, Acute / pathology
Leukemia, Experimental / pathology*
Reg. No./Substance:
0/Acetamides; 14875-96-8/Heme; 3073-59-4/hexamethylene bisacetamide; 67-68-5/Dimethyl Sulfoxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Limiting-dilution analysis for the determination of leukemic cell frequencies after bone marrow deco...
Next Document:  Reciprocal translocation involving the short arms of chromosomes 7 and 11, t(7p-;11p+), associated w...